Wall Street equity research analysts covering 908 Devices Inc. (NASDAQ: MASS) generally maintain positive sentiment, with consensus recommendations leaning toward a Buy or moderate buy rating. Financial institutions point to its innovative handheld chemical detection technology and growing adoption across public safety, defense, and life science markets as key growth drivers. While individual analyst price targets vary based on macroeconomic conditions and small-cap volatility, the overall outlook remains optimistic regarding its commercial scaling potential.